Related Experiment Video
Updated: Jun 17, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Monocyte expression of adhesion molecules during low- and high-flux polysulfone hemodialysis and the effect of
Aristeidis Stavroulopoulos1, Dimitrios Petras, Ioannis Kakavas
1Nephrology Department, IASIO Hospital - General Clinic of Kallithea, Athens, Greece. stavroulopoulos@yahoo.co.uk
Insights
Atorvastatin reduces monocyte activation during hemodialysis, regardless of membrane flux. Polysulfone dialysis itself activates monocytes, increasing CD11b/CD18 and decreasing CD62L expression.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Hemodialysis using polysulfone membranes can activate monocytes.
- Membrane flux (low-flux vs. high-flux) may influence this activation.
- Adhesion molecules on monocytes are key indicators of activation.
Purpose of the Study:
- To investigate the effect of atorvastatin on monocyte adhesion molecule expression.
- To determine if membrane flux influences monocyte activation during hemodialysis.
Main Methods:
- Studied CD11b, CD18, and CD62L expression on monocytes via flow cytometry.
- 32 hemodialysis patients were analyzed: 16 on low-flux (LFD) and 16 on high-flux (HFD) polysulfone membranes.
- Measurements were taken before and after dialysis, and after 6 months of atorvastatin (20 mg/day) administration.
Main Results:
- Hemodialysis increased CD11b and CD18 expression while decreasing CD62L expression on monocytes.
- Atorvastatin administration reduced pre-dialysis monocyte CD11b and CD18 expression and increased CD62L expression.
- No significant differences in adhesion molecule expression were observed between LFD and HFD groups.
Conclusions:
- The polysulfone dialysis process activates monocytes irrespective of membrane flux.
- Atorvastatin treatment is associated with a reduction in monocyte activation markers.
Background/Aims:
Aims of the present study are to examine the effects of atorvastatin administration and the influence of membrane flux on adhesion molecules expression on monocytes.
Methods:
We studied CD11b, CD18 and CD62L expression on monocytes (flow cytometry) in 32 patients, 16 on low-flux (LFD) and 16 on high-flux (HFD) polysulfone hemodialysis, before and after dialysis and also after administration of atorvastatin 20 mg/day for 6 months.
Results:
After hemodialysis, expression of CD11b and CD18 increased and expression of CD62L decreased. After atorvastatin administration there was a decrease in pre-dialysis monocyte expression of CD11b and CD18, and an increase in the expression of CD62L compared to pre-dialysis baseline values. There were no statistically significant differences in expression of all three molecules between LFD and HFD groups.
Conclusions:
Polysulfone dialysis process activates monocytes irrespectively of the membrane flux. Atorvastatin use is associated with reduced monocyte activation.
Related Concept Videos
Hemodialysis I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

